Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Kessler

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Patient Preference and Adherence|November 11, 2017
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyMichael Wang, Katharine Batt, Craig Kessler, et al.
Blood|January 10, 2002
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter studyPier M Mannucci, Juan Chediak, Wahid Hanna, et al.
European Journal of Haematology|March 3, 2018
Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) studyKatharine Batt, Lisa Boggio, Anne Neff, et al.
European Journal of Haematology|March 3, 2018
Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) studyTyler W Buckner, Katharine Batt, Doris Quon, et al.
Advances in Therapy|April 3, 2012
Advances in hemophilia care: report of two symposia at the Hemophilia 2010 World CongressGerry Dolan, Jussara Almeida Cruz, Elisabeth Steinhagen-Thiessen, et al.
Thrombosis and Haemostasis|February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit DeficiencyManuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Blood Reviews|March 30, 2019
Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasisBethany Samuelson Bannow, Michael Recht, Claude Négrier, et al.
Haematologica|May 9, 2020
International recommendations on the diagnosis and treatment of acquired hemophilia AAndreas Tiede, Peter Collins, Paul Knoebl, et al.
American Journal of Hematology|February 19, 2021
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationEun-Ju Lee, Douglas B Cines, Terry Gernsheimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerNaiyer A Rizvi, John L Marshall, Elizabeth Ness, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Patient Preference and Adherence|November 11, 2017
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyMichael Wang, Katharine Batt, Craig Kessler, et al.
Blood|January 10, 2002
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter studyPier M Mannucci, Juan Chediak, Wahid Hanna, et al.
European Journal of Haematology|March 3, 2018
Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) studyKatharine Batt, Lisa Boggio, Anne Neff, et al.
European Journal of Haematology|March 3, 2018
Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) studyTyler W Buckner, Katharine Batt, Doris Quon, et al.
Advances in Therapy|April 3, 2012
Advances in hemophilia care: report of two symposia at the Hemophilia 2010 World CongressGerry Dolan, Jussara Almeida Cruz, Elisabeth Steinhagen-Thiessen, et al.
Thrombosis and Haemostasis|February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit DeficiencyManuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Blood Reviews|March 30, 2019
Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasisBethany Samuelson Bannow, Michael Recht, Claude Négrier, et al.
Haematologica|May 9, 2020
International recommendations on the diagnosis and treatment of acquired hemophilia AAndreas Tiede, Peter Collins, Paul Knoebl, et al.
American Journal of Hematology|February 19, 2021
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationEun-Ju Lee, Douglas B Cines, Terry Gernsheimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerNaiyer A Rizvi, John L Marshall, Elizabeth Ness, et al.
Pageof 5